World Clinical Chemistry Analyzers & Reagents Market

World Clinical Chemistry Analyzers & Reagents Market

This report analyzes the worldwide markets for Clinical Chemistry Analyzers in Millions of US$. The major product segments analyzed are Analyzers (Large Volume Clinical Chemistry, Medium Sized Clinical Chemistry, & Small Sized Clinical Chemistry), and Reagents (Metabolite Chemistry Reagents, Enzyme Chemistry Reagents, Electrolyte Chemistry Reagents, & Other Chemistry Reagents). The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Latin America. Annual forecasts are provided for each region for the period of 2000 through 2015. The report profiles 79 companies including many key and niche players worldwide such as Abbott Laboratories, Alfa Wassermann, Inc., Beckman Coulter, Inc., Cholestech Corporation, Hemagen Diagnostics, Inc., Ortho-Clinical Diagnostics, Olympus America, Roche Diagnostics, Siemens Healthcare Diagnostics, Inc., Sigma-Aldrich, and Sysmex Corporation. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

CLINICAL CHEMISTRY ANALYZERS AND REAGENTS MCP-3509
A GLOBAL STRATEGIC BUSINESS REPORT


CONTENTS


I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations I-1
Disclaimers I-2
Data Interpretation & Reporting Level I-2
Quantitative Techniques & Analytics I-2
Product Definitions and Scope of Study I-3
Clinical Chemistry Analyzers I-3
Large Volume Clinical Chemistry Analyzers I-3
Medium Sized Clinical Chemistry Analyzers I-3
Small Sized Clinical Chemistry Analyzers I-4
Reagents I-4
Metabolite Chemistry Reagents I-4
Enzyme Chemistry Reagents I-4
Electrolyte Chemistry Reagents I-4


II. EXECUTIVE SUMMARY

1. Market Overview II-1
A Quick Primer II-1
Analyzers and Sensors Transform Clinical Diagnostics II-1
Clinical Laboratory Automation-Order of the Day II-1
Mass Spectrometry – A New Dimension in Clinical Diagnostics II-2
Nanotechnology Shapes the Future of Clinical Labs II-2
Northward Bound of Point-of-Care Testing II-2
Integrated Systems Cannibalize Single Unit Sales II-3

2. Diagnostic Industry Overview II-4
Exhibiting Rapid Change II-4
IVD Industry – An Overview II-4
Table 1: In Vitro-Diagnostic Market Worldwide (2004):
Percentage Share Breakdown of Revenues Generated by Segment
(includes corresponding Graph/Chart) II-4

Table 2: Leading Players in the Global IVD Market (2004):
Percentage Share Breakdown by Value sales for Roche
Diagnostics, Abbott, J&J/Ortho Clinical Diagnostics, Bayer,
Beckman Coulter, and Others (includes corresponding
Graph/Chart) II-5

Table 3: Leading Players in the Global Clinical Chemistry
Testing Market for 2001 & 2005: Market Share by Value Sales
for Roche, Beckman Coulter, Dade Behring, Bayer,
Ortho-Clinical Diagnostics, Abbott, and Others (includes
corresponding Graph/Chart) II-5
Chemical Analysis – An Overview II-6
Human Anatomy is Chemistry Driven II-6
History of Chemical Analysis II-6
Chemical Tests To Determine the Concentration of Substances II-6
Table 4: Most Commonly Used Blood Tests II-7

3. Product Overview II-8
Analyzers II-8
What are Clinical Chemistry Analyzers? II-8
Large Volume Clinical Chemistry Analyzers II-8
Medium Sized Clinical Chemistry Analyzers II-8
Small Sized Clinical Chemistry Analyzers II-8
Automated Analytical Methods II-8
Automated Analyzers II-9
Continuous Flow Analysis II-9
Discrete Analysis II-9
Test Tube Analyzers: Perennial Symbol of the Chemical
Laboratory II-9
Advantages and Disadvantages of Test Tube Analyzers II-10
Reagents II-10
Different Applications of Reagents II-10
Metabolite Chemistry Reagents II-10
Enzyme Chemistry Reagents II-10
Electrolyte Chemistry Reagents II-10

4. Role of Computers in Clinical Chemistry II-11
Clinical Data Interpretation Supported by Computerization II-11
Bar Coding used to Increase Accuracy and Productivity II-11
Sample and Data Collection Process II-11
Modes in Clinical Chemistry for Sample Processing II-12
Batch Processing Mode: Test Oriented II-12
Random-access Processing Mode: Patient Oriented II-12

5. Clinical Laboratory Testing Services II-14
Hospital Testing Services II-14
Commercial Laboratories II-14
Physician’s Office Laboratories II-14

6. Product Introductions II-15
Siemens Introduces DCA Vantage Analyzer for Diabetes Management II-15
Siemens Healthcare Introduces Folate, B12, and Ferritin Tests II-15
Beckman Coulter Launches Amylase EPS-G7 Assay II-15
Olympus Launches Automated AU680® Analyzer II-15
Agappe Unveils New Diagnostic Products in India II-16
Roche Diagnostics Extends HCV Immunoassay’s Availability II-16
Abbott Laboratories Enhances Architect® Analyzers II-16
Roche Diagnostics to Unveil New Products in Japan II-16
Applied Biosystems Expands Labeling Chemistry Reagents Line II-16
Olympus Unveils New Thyroid Panel for Immunoassay System II-17
Miraculins to Develop Clinical Immunoassays II-17
Olympus Offers Ready-for-Use Reagents for the PK®7200 II-17
Beckman Coulter Unveils UniCel® DxI 600 II-17
Olympus Launches D-Dimer® Reagent II-18
Olympus Launches AU680® Chemistry-Immuno Analyzer II-18
Ortho-Clinical Launches Improved Sensitivity Troponin I Assay II-18
Siemens Healthcare Launches Version 2.0 Software II-19
Abaxis Introduces Unique 5-part Differential Veterinary
Hematology Analyzer II-19
Roche Diagnostics Launches Clinical Chemistry Analyzer II-19
Siemens Healthcare Diagnostics Offers ADVIA 1800 Worldwide II-20
Siemens Adds Clinitek Advantus to Clinitek Urine Analyzers
Product Line II-20
IDEXX Laboratories Introduces Diagnostic Health Profile II-20
Heska Corporation Unveils Dri Chem 4000 Chemistry Analyzer II-21
Sysmex Introduces HISCL-2000i II-21
Sysmex Introduces Automated Hematology Analyzer XE-5000 In
Europe II-21
Siemens Healthcare Introduces DCA Vantage™ Analyzer II-21
Idexx Launches QC Panel for VetTest Chemistry Analyzer II-21
IRIS International Launches Urine Chemistry Analyzer II-22
Sysmex Launches Automated Hematology Analyzer II-22
Dade Behring Introduces Tacrolimus Test for Analyzers II-22
Sysmex to Introduce Automated Clinical Chemistry Analyzer in
Asia II-22
Toshiba Launches Automated Clinical Chemistry Analyzer II-23
Ortho-Clinical Diagnostics Unveils New Micro Tip™ Assay II-23
Bayer HealthCare Expands Chemistry Testing Portfolio II-23
Olympus Showcases AU400 Chemistry Analyzer II-23
Dade Behring Develops Dimension VISTA II-23
Bayer Rolls Out IMS Analyzer II-24
Bayer Introduces Urinalysis System II-24
Bayer HealthCare Introduces ADVIA WorkCellTM CDX II-24
Bayer Rolls out ADVIA 1200 Analyzer II-24
Ortho Diagnostics Launches VITROS 350 Chemistry System II-24
Beckman Expands UniCel Instruments Portfolio II-24
Polymedco Launches SPOTCHEM EZ- Chemistry Analyzer II-25
Ortho-Clinical Extends Testing Capabilities For the VITROS
Chemistry System II-25
Abbott Unveils Cancer Tests for ARCHITECT Analyzers II-25
Abbott Rolls Out 10 Clinical Chemistry Tests II-25
Abbott Laboratories Unveil New Assays for Therapeutic Drug
Monitoring Management II-26
Roche Diagnostics Rolls Out OMNI S 1-4 Models II-26
Roche Diagnostics Launches Urine Test Strip Analyzer II-26
Applied Biosystems Unveils BloodPrep Chemistry II-26

7. Recent Industry Activity II-27
Hologic to Take Over Third Wave II-27
Miltenyi Announces Acquisition of Medic Tools II-27
Drew Scientific Acquires JAS II-27
Olympus Receives FDA Approval for PK® Blood Grouping Reagents II-27
Ortho-Clinical Secures FDA Clearance for Latest HIV Test II-27
Bracco Acquires E-Z-EM II-28
Corgenix Inks Product Development and Distribution Agreement
with Randox II-28
Quest Diagnostics Signs Long-term Agreement with Roche II-28
Novation Renews Agreement with Olympus to Purchase Chemistry
Systems II-29
Sysmex Enters into Joint Venture Agreement with bioMérieux II-29
Third Wave Expands Core Intellectual Property Portfolio II-29
Olympus to Provide Middleware Solutions for Clinical
Laboratories II-29
Fangyuan Pharmaceutical, IMDi Agree on Sino-Russian
Biological Diagnosis Reagents Project II-30
Siemens Acquires Dade Behring II-30
Cliniqa Acquires Assets of Reagents Applications II-30
Cliniqa Acquires Assets of King Diagnostics and Compass
Bioscience II-30
Genzyme to Take Over Diagnostic Chemicals’ Diagnostic Division II-31
Clinical Data Divests Vital Scientific for US$19.5 million II-31
DiaSys Takes Over French Polès II-31
Siemens Healthcare Extends Distribution Accord with Sysmex II-31
Abaxis Signs Distribution Accord with McKesson II-32
Alfa Signs Distribution Accord with Hitachi II-32
Iris Signs Multi year Sales and Service Supply Accord with
Amerinet II-32
Clinical Data Signs Accord with Sclavo Diagnostics International II-32
Premier Provides Roche HIV-1 Test Access to Members II-33
Roche Diagnostics Inks Contracts with Novation II-33
MedAssets Inks Contract with Siemens Healthcare II-33
Siemens Healthcare Diagnostics Inks Agreement with Amerinet II-33
Premier Selects Siemens Healthcare to Offer Integrated
Urinalysis Solutions II-34
Roche Acquires BioVeris II-34
Sigma-Aldrich and Sangamo BioSciences Enter into Global Alliance II-34
Sysmex Establishes Sysmex Canada II-34
Sysmex Inks an Agreement with bioMerieux for Urinary Screening II-35
Inverness Acquires Cholestech II-35
Bio-Rad Inks Marketing Agreement with Siemens Healthcare II-35
Roche Receives FDA Approval for HIV-1 Test II-35
Roche Diagnostics and Sysmex Extend Distribution Agreement II-36
Sysmex Sign R&D and Clinical Development Agreements with
Affymetrix II-36
Abaxis and HSIC Enter into Distribution Agreement II-36
Siemens Acquires Diagnostic Products II-36
Bayer Diagnostics and DPC Merged to Form Siemens Healthcare
Diagnostics II-37
Olympus Enters into Distribution Agreement with PSS World
Medical II-37
FDA Grants 510(k) Clearance for iChem 100 II-37
FDA Clears cobas 6000 Analyzer Range II-37
Sysmex Signs an Agreement with Roche Diagnostics II-37
Olympus Expands Immunoessay R&D Center II-38
NSAID Panel to Support VetTest® Chemistry Analyzer II-38
Thermo and DP Enter into an Agreement for Clinical Chemistry
Platform II-38
Clinical Data Inks Master Distribution Agreement with Daiichi
Pure Chemicals II-38
Ortho-Clinical Diagnostics Receives FDA Clearance for
Lipoprotein Assay II-39
IRIS Renews Agreement with ARKRAY II-39
Abbott Extends Assays to Diagnostic Laboratories II-39
Hemagen Receives FDA Stamp of Approval for Liquid Stable
Reagents II-39
Abbott and Seradyn Obtain FDA Clearance for Hemoglobin Test
for Diabetes II-39
Beckman Receives Approval for New Clinical Chemistry Analyzers II-40
Abbott Acquires I-Stat II-40
Hemagen Diagnostics Extends Supply Agreement with Roche II-40
Vital Scientific Bags FDA Clearance for V-Twin and Selectra XL II-40
Sysmex Bags Approval for Manufacturing Item 23 Clinical
Chemistry Reagents II-40
Sysmex Initiates Marketing of RANREAM HCV II EX Reagent in Japan II-40
Invitrogen Bags Products and Technology Rights from Vertex II-41
diaDexus to Supply Analyte Specific Reagents to Mayo II-41

8. Focus on Select Global Players II-42
Abbott Laboratories (US) II-42
Alfa Wassermann, Inc.(US) II-42
Beckman Coulter, Inc.(US) II-43
Cholestech Corporation (US) II-43
Hemagen Diagnostics, Inc.(US) II-44
Ortho-Clinical Diagnostics (US) II-44
Olympus America (US) II-44
Roche Diagnostics (US) II-45
Siemens Healthcare Diagnostics, Inc (US) II-45
Sigma-Aldrich (US) II-46
Sysmex Corporation (Japan) II-46

9. Global Market Perspective II-47
Table 5: World Recent Past, Current & Future Analysis for
Clinical Chemistry Analyzers and Reagents by Geographic Region
- US, Canada, Japan, Europe, Asia–Pacific (excluding Japan)
and Latin American Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2000 through 2010
(includes corresponding Graph/Chart) II-47

Table 6: World Long-term Projections for Clinical Chemistry
Analyzers and Reagents by Geographic Region – US, Canada,
Japan, Europe, Asia-Pacific (excluding Japan) and Latin
American Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2011 through 2015 (includes
corresponding Graph/Chart) II-48

Table 7: World 10-Year Perspective for Clinical Chemistry
Analyzers and Reagents by Geographic Region - Percentage
Breakdown of Dollar Sales for US, Canada, Japan, Europe,
Asia–Pacific (excluding Japan) and Latin American Markets for
Years 2003, 2008 & 2012 (includes corresponding Graph/Chart) II-49

Table 8: World Recent Past, Current & Future Analysis for
Analyzers by Geographic Region - US, Canada, Japan, Europe,
Asia–Pacific (excluding Japan) and Latin American Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2010 (includes corresponding
Graph/Chart) II-50

Table 9: World Long-term Projections for Analyzers by
Geographic Region – US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan) and Latin American Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2011 through 2015 (includes corresponding Graph/Chart) II-51

Table 10: World 10-Year Perspective for Analyzers by
Geographic Region - Percentage Breakdown of Dollar Sales for
US, Canada, Japan, Europe, Asia–Pacific (excluding Japan) and
Latin American Markets for Years 2003, 2008 & 2012 (includes
corresponding Graph/Chart) II-52

Table 11: World Recent Past, Current & Future Analysis for
Analyzers by Product Segment - Large Volume Clinical Chemistry
Analyzers, Medium Sized Clinical Chemistry Analyzers and Small
Sized Clinical Chemistry Analyzers Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2000 through 2010 (includes corresponding Graph/Chart) II-53

Table 12: World Long-term Projections for Analyzers by Product
Segment - Large Volume Clinical Chemistry Analyzers, Medium
Sized Clinical Chemistry Analyzers and Small Sized Clinical
Chemistry Analyzers Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2011 through 2015
(includes corresponding Graph/Chart) II-54

Table 13: World 10-Year Perspective for Analyzers by Product
Segment – Percentage Breakdown of Dollar Sales for Large
Volume Clinical Chemistry Analyzers, Medium Sized Clinical
Chemistry Analyzers and Small Sized Clinical Chemistry
Analyzers Markets for 2003, 2008 & 2012 (includes
corresponding Graph/Chart) II-55

Table 14: World Recent Past, Current & Future Analysis for
Large Volume Clinical Chemistry Analyzers by Geographic Region
- US, Canada, Japan, Europe, Asia–Pacific (excluding Japan)
and Latin American Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2000 through 2010
(includes corresponding Graph/Chart) II-56

Table 15: World Long-term Projections for Large Volume
Clinical Chemistry Analyzers by Geographic Region – US,
Canada, Japan, Europe, Asia-Pacific (excluding Japan), and
Latin American Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2011 through 2015
(includes corresponding Graph/Chart) II-57

Table 16: World 10-Year Perspective for Large Volume Clinical
Chemistry Analyzers by Geographic Region - Percentage
Breakdown of Dollar Sales for US, Canada, Japan, Europe,
Asia–Pacific (excluding Japan) and Latin American Markets for
Years 2003, 2008 & 2012 (includes corresponding Graph/Chart) II-58

Table 17: World Recent Past, Current & Future Analysis for
Medium Sized Clinical Chemistry Analyzers by Geographic Region
- US, Canada, Japan, Europe, Asia–Pacific (excluding Japan)
and Latin American Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2000 through 2010
(includes corresponding Graph/Chart) II-59

Table 18: World Long-term Projections for Medium Sized
Clinical Chemistry Analyzers by Geographic Region – US,
Canada, Japan, Europe, Asia-Pacific (excluding Japan) and
Latin American Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2011 through 2015
(includes corresponding Graph/Chart) II-60

Table 19: World 10-Year Perspective for Medium Sized Clinical
Chemistry Analyzers by Geographic Region - Percentage
Breakdown of Dollar Sales for US, Canada, Japan, Europe,
Asia–Pacific (excluding Japan) and Latin American Markets for
Years 2003, 2008 & 2012 (includes corresponding Graph/Chart) II-61

Table 20: World Recent Past, Current & Future Analysis for
Small Sized Clinical Chemistry Analyzers by Geographic Region
- US, Canada, Japan, Europe, Asia–Pacific (excluding Japan)
and Latin American Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2000 through 2010
(includes corresponding Graph/Chart) II-62

Table 21: World Long-term Projections for Small Sized
Clinical Chemistry Analyzers by Geographic Region – US,
Canada, Japan, Europe, Asia-Pacific (excluding Japan), and
Latin American Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2011 through 2015
(includes corresponding Graph/Chart) II-63

Table 22: World 10-Year Perspective for Small Sized Clinical
Chemistry Analyzers by Geographic Region - Percentage
Breakdown of Dollar Sales for US, Canada, Japan, Europe,
Asia–Pacific (excluding Japan) and Latin American Markets for
Years 2003, 2008 & 2012 (includes corresponding Graph/Chart) II-64

Table 23: World Recent Past, Current & Future Analysis for
Reagents by Geographic Region - US, Canada, Japan, Europe,
Asia–Pacific (excluding Japan) and Latin American Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2010 (includes corresponding
Graph/Chart) II-65

Table 24: World Long-term Projections for Reagents by
Geographic Region – US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), and Latin American Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2011 through 2015 (includes corresponding Graph/Chart) II-66

Table 25: World 10-Year Perspective for Reagents by Geographic
Region - Percentage Breakdown of Dollar Sales for US, Canada,
Japan, Europe, Asia–Pacific (excluding Japan) and Latin
American Markets for Years 2003, 2008 & 2012 (includes
corresponding Graph/Chart) II-67

Table 26: World Recent Past, Current & Future Analysis for
Reagents by Product Segment- Metabolite Chemistry Reagents,
Enzyme Chemistry Reagents, Electrolyte Chemistry Reagents, and
Other Chemistry Reagents Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2000 through
2010 (includes corresponding Graph/Chart) II-68

Table 27: World Long-term Projections for Reagents by Product
Segment- Metabolite Chemistry Reagents, Enzyme Chemistry
Reagents, Electrolyte Chemistry Reagents, and Other Chemistry
Reagents Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2011 through 2015 (includes
corresponding Graph/Chart) II-69

Table 28: World 10-Year Perspective for Reagents by Product
Segment – Percentage Breakdown of Dollar Sales for Metabolite
Chemistry Reagents, Enzyme Chemistry Reagents, Electrolyte
Chemistry Reagents, & Other Chemistry Reagents Markets for
2003, 2008 & 2012 (includes corresponding Graph/Chart) II-70

Table 29: World Recent Past, Current & Future Analysis for
Metabolite Chemistry Reagents by Geographic Region - US,
Canada, Japan, Europe, Asia–Pacific (excluding Japan) and
Latin American Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2000 through 2010
(includes corresponding Graph/Chart) II-71

Table 30: World Long-term Projections for Metabolite Chemistry
Reagents by Geographic Region – US, Canada, Japan, Europe,
Asia-Pacific (excluding Japan), and Latin American Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2011 through 2015 (includes corresponding
Graph/Chart) II-72

Table 31: World 10-Year Perspective for Metabolite Chemistry
Reagents by Geographic Region - Percentage Breakdown of Dollar
Sales for US, Canada, Japan, Europe, Asia–Pacific (excluding
Japan) and Latin American Markets for Years 2003, 2008 & 2012
(includes corresponding Graph/Chart) II-73

Table 32: World Recent Past, Current & Future Analysis for
Enzyme Chemistry Reagents by Geographic Region - US, Canada,
Japan, Europe, Asia–Pacific (excluding Japan) and Latin
American Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2000 through 2010 (includes
corresponding Graph/Chart) II-74

Table 33: World Long-term Projections for Enzyme Chemistry
Reagents by Geographic Region – US, Canada, Japan, Europe,
Asia-Pacific (excluding Japan), and Latin American Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2011 through 2015 (includes corresponding
Graph/Chart) II-75

Table 34: World 10-Year Perspective for Enzyme Chemistry
Reagents by Geographic Region - Percentage Breakdown of Dollar
Sales for US, Canada, Japan, Europe, Asia–Pacific (excluding
Japan) and Latin American Markets for Years 2003, 2008 & 2012
(includes corresponding Graph/Chart) II-76

Table 35: World Recent Past, Current & Future Analysis for
Electrolyte Chemistry Reagents by Geographic Region - US,
Canada, Japan, Europe, Asia–Pacific (excluding Japan) and
Latin American Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2000 through 2010
(includes corresponding Graph/Chart) II-77

Table 36: World Long-term Projections for Electrolyte
Chemistry Reagents by Geographic Region – US, Canada, Japan,
Europe, Asia-Pacific (excluding Japan), and Latin American
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2011 through 2015 (includes
corresponding Graph/Chart) II-78

Table 37: World 10-Year Perspective for Electrolyte Chemistry
Reagents by Geographic Region - Percentage Breakdown of Dollar
Sales for US, Canada, Japan, Europe, Asia–Pacific (excluding
Japan) and Latin American Markets for Years 2003, 2008 & 2012
(includes corresponding Graph/Chart) II-79

Table 38: World Recent Past, Current & Future Analysis for
Other Chemistry Reagents by Geographic Region - US, Canada,
Japan, Europe, Asia–Pacific (excluding Japan) and Latin
American Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2000 through 2010 (includes
corresponding Graph/Chart) II-80

Table 39: World Long-term Projections for Other Chemistry
Reagents by Geographic Region – US, Canada, Japan, Europe,
Asia-Pacific (excluding Japan), and Latin American Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2011 through 2015 (includes corresponding
Graph/Chart) II-81

Table 40: World 10-Year Perspective for Other Chemistry
Reagents by Geographic Region - Percentage Breakdown of Dollar
Sales for US, Canada, Japan, Europe, Asia–Pacific (excluding
Japan) and Latin American Markets for Years 2003, 2008 & 2012
(includes corresponding Graph/Chart) II-82


III. MARKET

1. The United States III-1
A.Market Analysis III-1
Current and Future Analysis III-1
Ageing Population Creates More Opportunities III-1
Trends in the Clinical Chemistry Analyzers Market III-1
Reagent Rental Contracts Offer Viable Solution for Cost-
Cuttings III-1
US Clinical Laboratory Analyzer Market III-2
Table 41: Leading Players in the US Clinical Chemistry
Analyzers Market (2003-2005): Percentage Share Breakdown by
Value Sales (*) for Beckman Coulter, Roche, Olympus, Ortho
Clinical Diagnostics, Dade Behring, Bayer, Abbott, and
Others (includes corresponding Graph/Chart) III-2

Table 42: Leading Players in the US Clinical Chemistry
Reagents Market (2003-2005): Percentage Share Breakdown by
Value Sales (*) for Beckman Coulter, Roche, Ortho Clinical
Diagnostics, Dade Behring, and Others (includes
corresponding Graph/Chart) III-3
CLIA- Regulatory Framework of Diagnostic Testing III-3
Product Introductions/Launches III-3
Strategic Corporate Developments III-14
Focus on Select US Players III-25
B.Market Analytics III-30
Table 43: US Recent Past, Current & Future Analysis for
Clinical Chemistry Analyzers and Reagents by Product
Segment- Analyzers (Large Volume Clinical Chemistry, Medium
Sized Clinical Chemistry, and Small Sized Clinical
Chemistry), and Reagents (Metabolite Chemistry Reagents,
Enzyme Chemistry Reagents, Electrolyte Chemistry Reagents,
and Other Chemistry Reagents) Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2000
through 2010 (includes corresponding Graph/Chart) III-30

Table 44: US Long-term Projections for Clinical Chemistry
Analyzers and Reagents by Product Segment- Analyzers (Large
Volume Clinical Chemistry, Medium Sized Clinical Chemistry,
and Small Sized Clinical Chemistry), and Reagents
(Metabolite Chemistry Reagents, Enzyme Chemistry Reagents,
Electrolyte Chemistry Reagents, and Other Chemistry
Reagents) Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2011 through 2015 (includes
corresponding Graph/Chart) III-31

Table 45: US 10-Year Perspective for Clinical Chemistry
Analyzers and Reagents by Product Segment – Percentage
Breakdown of Dollar Sales for Analyzers (Large Volume
Clinical Chemistry, Medium Sized Clinical Chemistry, and
Small Sized Clinical Chemistry), and Reagents (Metabolite
Chemistry Reagents, Enzyme Chemistry Reagents, Electrolyte
Chemistry Reagents, and Other Chemistry Reagents) Markets
for 2003, 2008 & 2012 (includes corresponding Graph/Chart) III-32

2. Canada III-33
A.Market Analysis III-33
Current and Future Analysis III-33
An Overview of the Medical Equipment Market III-33
Strategic Corporate Developments III-33
Focus on Key Canadian Player III-34
B.Market Analytics III-34
Table 46: Canadian Recent Past, Current & Future Analysis
for Clinical Chemistry Analyzers and Reagents by Product
Segment- Analyzers (Large Volume Clinical Chemistry, Medium
Sized Clinical Chemistry, and Small Sized Clinical
Chemistry), and Reagents (Metabolite Chemistry Reagents,
Enzyme Chemistry Reagents, Electrolyte Chemistry Reagents,
and Other Chemistry Reagents) Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2000
through 2010 (includes corresponding Graph/Chart) III-34

Table 47: Canadian Long-term Projections for Clinical
Chemistry Analyzers and Reagents by Product Segment-
Analyzers (Large Volume Clinical Chemistry, Medium Sized
Clinical Chemistry, and Small Sized Clinical Chemistry), and
Reagents (Metabolite Chemistry Reagents, Enzyme Chemistry
Reagents, Electrolyte Chemistry Reagents, and Other
Chemistry Reagents) Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2011 through
2015 (includes corresponding Graph/Chart) III-35

Table 48: Canadian 10-Year Perspective for Clinical
Chemistry Analyzers and Reagents by Product Segment –
Percentage Breakdown of Dollar Sales for Analyzers (Large
Volume Clinical Chemistry, Medium Sized Clinical Chemistry,
and Small Sized Clinical Chemistry), and Reagents
(Metabolite Chemistry Reagents, Enzyme Chemistry Reagents,
Electrolyte Chemistry Reagents, and Other Chemistry
Reagents) Markets for 2003, 2008 & 2012 (includes
corresponding Graph/Chart) III-36

3. Japan III-37
A.Market Analysis III-37
Current and Future Analysis III-37
Strategic Corporate Developments III-37
Product Introductions/Launches III-39
Focus on Key Japanese Player III-39
B.Market Analytics III-40
Table 49: Japanese Recent Past, Current & Future Analysis
for Clinical Chemistry Analyzers and Reagents by Product
Segment- Analyzers (Large Volume Clinical Chemistry, Medium
Sized Clinical Chemistry, and Small Sized Clinical
Chemistry), and Reagents (Metabolite Chemistry Reagents,
Enzyme Chemistry Reagents, Electrolyte Chemistry Reagents,
and Other Chemistry Reagents) Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2000
through 2010 (includes corresponding Graph/Chart) III-40

Table 50: Japanese Long-term Projections for Clinical
Chemistry Analyzers and Reagents by Product Segment-
Analyzers (Large Volume Clinical Chemistry, Medium Sized
Clinical Chemistry, and Small Sized Clinical Chemistry), and
Reagents (Metabolite Chemistry Reagents, Enzyme Chemistry
Reagents, Electrolyte Chemistry Reagents, and Other
Chemistry Reagents) Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2011 through
2015 (includes corresponding Graph/Chart) III-41

Table 51: Japanese 10-Year Perspective for Clinical
Chemistry Analyzers and Reagents by Product Segment –
Percentage Breakdown of Dollar Sales for Analyzers (Large
Volume Clinical Chemistry, Medium Sized Clinical Chemistry,
and Small Sized Clinical Chemistry), and Reagents
(Metabolite Chemistry Reagents, Enzyme Chemistry Reagents,
Electrolyte Chemistry Reagents, and Other Chemistry
Reagents) Markets for 2003, 2008 & 2012(includes
corresponding Graph/Chart) III-42

4. Europe III-43
A.Market Analysis III-43
Current and Future Analysis III-43
European Immunochemistry Analyzers Market: An Overview III-43
Table 52: Leading Players in the European Immunochemistry
Analysers Market (2007): Percentage Share Breakdown of
Value Sales for Roche Diagnostics, Siemens Medical
Solutions Diagnostics, Abbott Diagnostics, Beckman Coulter,
Dade Behring, Ortho Clinical Diagnostics, and Others
(includes corresponding Graph/Chart) III-44
Western Europe III-44
New Technologies Drive In Vitro Diagnostics Market Growth III-44
Product Launches III-45
B.Market Analytics III-46
Table 53: European Recent Past, Current & Future Analysis
for Clinical Chemistry Analyzers and Reagents by Geographic
Region- France, Germany, Italy, UK, and Rest of Europe
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2000 through 2010 (includes
corresponding Graph/Chart) III-46

Table 54: European Long-term Projections for Clinical
Chemistry Analyzers and Reagents by Geographic Region-
France, Germany, Italy, UK, and Rest of Europe Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2011 through 2015 (includes corresponding
Graph/Chart) III-47

Table 55: European 10-Year Perspective for Clinical
Chemistry Analyzers and Reagents by Geographic Region-
Percentage Breakdown of Dollar Sales for France, Germany,
Italy, UK, and Rest of Europe Markets for Years 2003, 2008
& 2012 (includes corresponding Graph/Chart) III-48

Table 56: European Recent Past, Current & Future Analysis
for Clinical Chemistry Analyzers and Reagents by Product
Segment- Analyzers (Large Volume Clinical Chemistry, Medium
Sized Clinical Chemistry, and Small Sized Clinical
Chemistry), and Reagents (Metabolite Chemistry Reagents,
Enzyme Chemistry Reagents, Electrolyte Chemistry Reagents,
and Other Chemistry Reagents) Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2000
through 2010 (includes corresponding Graph/Chart) III-49

Table 57: European Long-term Projections for Clinical
Chemistry Analyzers and Reagents by Product Segment-
Analyzers (Large Volume Clinical Chemistry, Medium Sized
Clinical Chemistry, and Small Sized Clinical Chemistry), and
Reagents (Metabolite Chemistry Reagents, Enzyme Chemistry
Reagents, Electrolyte Chemistry Reagents, and Other
Chemistry Reagents) Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2011 through
2015 (includes corresponding Graph/Chart) III-50

Table 58: European 10-Year Perspective for Clinical
Chemistry Analyzers and Reagents by Product Segment –
Percentage Breakdown of Dollar Sales for Analyzers (Large
Volume Clinical Chemistry, Medium Sized Clinical Chemistry,
and Small Sized Clinical Chemistry), and Reagents
(Metabolite Chemistry Reagents, Enzyme Chemistry Reagents,
Electrolyte Chemistry Reagents, and Other Chemistry
Reagents) Markets for 2003, 2008 & 2012 (includes
corresponding Graph/Chart) III-51

4a. France III-52
A.Market Analysis III-52
Current and Future Analysis III-52
Clinical Chemistry Market In France III-52
French Laboratory Equipment Market III-52
Strategic Corporate Developments III-53
B.Market Analytics III-54
Table 59: French Recent Past, Current & Future Analysis for
Clinical Chemistry Analyzers and Reagents by Product
Segment- Analyzers (Large Volume Clinical Chemistry, Medium
Sized Clinical Chemistry, and Small Sized Clinical
Chemistry), and Reagents (Metabolite Chemistry Reagents,
Enzyme Chemistry Reagents, Electrolyte Chemistry Reagents,
and Other Chemistry Reagents) Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2000
through 2010 (includes corresponding Graph/Chart) III-54

Table 60: French Long-term Projections for Clinical
Chemistry Analyzers and Reagents by Product Segment-
Analyzers (Large Volume Clinical Chemistry, Medium Sized
Clinical Chemistry, and Small Sized Clinical Chemistry), and
Reagents (Metabolite Chemistry Reagents, Enzyme Chemistry
Reagents, Electrolyte Chemistry Reagents, and Other
Chemistry Reagents) Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2011 through
2015 (includes corresponding Graph/Chart) III-55

Table 61: French 10-Year Perspective for Clinical Chemistry
Analyzers and Reagents by Product Segment – Percentage
Breakdown of Dollar Sales for Analyzers (Large Volume
Clinical Chemistry, Medium Sized Clinical Chemistry, and
Small Sized Clinical Chemistry), and Reagents (Metabolite
Chemistry Reagents, Enzyme Chemistry Reagents, Electrolyte
Chemistry Reagents, and Other Chemistry Reagents) Markets
for 2003, 2008 & 2012 (includes corresponding Graph/Chart) III-56

4b. Germany III-57
A.Market Analysis III-57
Current and Future Analysis III-57
Strategic Corporate Developments III-57
B.Market Analytics III-58
Table 62: German Recent Past, Current & Future Analysis for
Clinical Chemistry Analyzers and Reagents by Product
Segment- Analyzers (Large Volume Clinical Chemistry, Medium
Sized Clinical Chemistry, and Small Sized Clinical
Chemistry), and Reagents (Metabolite Chemistry Reagents,
Enzyme Chemistry Reagents, Electrolyte Chemistry Reagents,
and Other Chemistry Reagents) Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2000
through 2010 (includes corresponding Graph/Chart) III-58

Table 63: German Long-term Projections for Clinical
Chemistry Analyzers and Reagents by Product Segment-
Analyzers (Large Volume Clinical Chemistry, Medium Sized
Clinical Chemistry, and Small Sized Clinical Chemistry), and
Reagents (Metabolite Chemistry Reagents, Enzyme Chemistry
Reagents, Electrolyte Chemistry Reagents, and Other
Chemistry Reagents) Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2011 through
2015 (includes corresponding Graph/Chart) III-59

Table 64: German 10-Year Perspective for Clinical Chemistry
Analyzers and Reagents by Product Segment – Percentage
Breakdown of Dollar Sales for Analyzers (Large Volume
Clinical Chemistry, Medium Sized Clinical Chemistry, and
Small Sized Clinical Chemistry), and Reagents (Metabolite
Chemistry Reagents, Enzyme Chemistry Reagents, Electrolyte
Chemistry Reagents, and Other Chemistry Reagents) Markets
for 2003, 2008 & 2012 (includes corresponding Graph/Chart) III-60

4c. Italy III-61
A. Market Analytics III-61
Current and Future Analysis III-61
Italian Laboratory Instruments Market III-61
B.Market Analytics III-62
Table 65: Italian Recent Past, Current & Future Analysis for
Clinical Chemistry Analyzers and Reagents by Product
Segment- Analyzers (Large Volume Clinical Chemistry, Medium
Sized Clinical Chemistry, and Small Sized Clinical
Chemistry), and Reagents (Metabolite Chemistry Reagents,
Enzyme Chemistry Reagents, Electrolyte Chemistry Reagents,
and Other Chemistry Reagents) Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2000
through 2010 (includes corresponding Graph/Chart) III-62

Table 66: Italian Long-term Projections for Clinical
Chemistry Analyzers and Reagents by Product Segment-
Analyzers (Large Volume Clinical Chemistry, Medium Sized
Clinical Chemistry, and Small Sized Clinical Chemistry), and
Reagents (Metabolite Chemistry Reagents, Enzyme Chemistry
Reagents, Electrolyte Chemistry Reagents, and Other
Chemistry Reagents) Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2011 through
2015 (includes corresponding Graph/Chart) III-63

Table 67: Italian 10-Year Perspective for Clinical Chemistry
Analyzers and Reagents by Product Segment – Percentage
Breakdown of Dollar Sales for Analyzers (Large Volume
Clinical Chemistry, Medium Sized Clinical Chemistry, and
Small Sized Clinical Chemistry), and Reagents (Metabolite
Chemistry Reagents, Enzyme Chemistry Reagents, Electrolyte
Chemistry Reagents, and Other Chemistry Reagents) Markets
for 2003, 2008 & 2012 (includes corresponding Graph/Chart) III-64

4d. The United Kingdom III-65
A.Market Analysis III-65
Current and Future Analysis III-65
UK Instrumentation Market III-65
Strategic Corporate Development III-65
B.Market Analytics III-66
Table 68: UK Recent Past, Current & Future Analysis for
Clinical Chemistry Analyzers and Reagents by Product
Segment- Analyzers (Large Volume Clinical Chemistry, Medium
Sized Clinical Chemistry, and Small Sized Clinical
Chemistry), and Reagents (Metabolite Chemistry Reagents,
Enzyme Chemistry Reagents, Electrolyte Chemistry Reagents,
and Other Chemistry Reagents) Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2000
through 2010 (includes corresponding Graph/Chart) III-66

Table 69: UK Long-term Projections for Clinical Chemistry
Analyzers and Reagents by Product Segment- Analyzers (Large
Volume Clinical Chemistry, Medium Sized Clinical Chemistry,
and Small Sized Clinical Chemistry), and Reagents
(Metabolite Chemistry Reagents, Enzyme Chemistry Reagents,
Electrolyte Chemistry Reagents, and Other Chemistry
Reagents) Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2011 through 2015 (includes
corresponding Graph/Chart) III-67

Table 70: UK 10-Year Perspective for Clinical Chemistry
Analyzers and Reagents by Product Segment – Percentage
Breakdown of Dollar Sales for Analyzers (Large Volume
Clinical Chemistry, Medium Sized Clinical Chemistry, and
Small Sized Clinical Chemistry), and Reagents (Metabolite
Chemistry Reagents, Enzyme Chemistry Reagents, Electrolyte
Chemistry Reagents, and Other Chemistry Reagents) Markets
for 2003, 2008 & 2012 (includes corresponding Graph/Chart) III-68

4e. Rest of Europe III-69
A. Market Analytics III-69
Current and Future Analysis III-69
Study of IVD Market in Spain III-69
Turkey III-69
Strategic Corporate Developments III-70
B.Market Analytics III-71
Table 71: Rest of Europe Recent Past, Current & Future
Analysis for Clinical Chemistry Analyzers and Reagents by
Product Segment- Analyzers (Large Volume Clinical Chemistry,
Medium Sized Clinical Chemistry, and Small Sized Clinical
Chemistry), and Reagents (Metabolite Chemistry Reagents,
Enzyme Chemistry Reagents, Electrolyte Chemistry Reagents,
and Other Chemistry Reagents) Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2000 through 2010 (includes corresponding Graph/Chart) III-71

Table 72: Rest of Europe Long-term Projections for Clinical
Chemistry Analyzers and Reagents by Product Segment-
Analyzers (Large Volume Clinical Chemistry, Medium Sized
Clinical Chemistry, and Small Sized Clinical Chemistry),
and Reagents (Metabolite Chemistry Reagents, Enzyme
Chemistry Reagents, Electrolyte Chemistry Reagents, and
Other Chemistry Reagents) Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2011
through 2015 (includes corresponding Graph/Chart) III-72

Table 73: Rest of Europe 10-Year Perspective for Clinical
Chemistry Analyzers and Reagents by Product Segment –
Percentage Breakdown of Dollar Sales for Analyzers (Large
Volume Clinical Chemistry, Medium Sized Clinical Chemistry,
and Small Sized Clinical Chemistry), and Reagents
(Metabolite Chemistry Reagents, Enzyme Chemistry Reagents,
Electrolyte Chemistry Reagents, and Other Chemistry
Reagents) Markets for 2003, 2008 & 2012 (includes
corresponding Graph/Chart) III-73

5. Asia-Pacific III-74
A. Market Analytics III-74
Current and Future Analysis III-74
Health-Care Industry in Asia-Pacific III-74
Key Asia-Pacific Markets III-74
China III-74
Australia III-75
Korea III-75
Clinical Chemistry Analyzers III-75
Table 74: Clinical Laboratory Instrumentation Market in
South Korea (2006): Percentage Share Breakdown of Value
Sales by Segment (includes corresponding Graph/Chart) III-75
Clinical Laboratory Products III-76
Indonesia III-76
Singapore III-76
Taiwan III-76
Strategic Corporate Development III-77
Product Launches III-77
B.Market Analytics III-78
Table 75: Asia-Pacific Recent Past, Current & Future
Analysis for Clinical Chemistry Analyzers and Reagents by
Product Segment- Analyzers (Large Volume Clinical Chemistry,
Medium Sized Clinical Chemistry, and Small Sized Clinical
Chemistry), and Reagents (Metabolite Chemistry Reagents,
Enzyme Chemistry Reagents, Electrolyte Chemistry Reagents,
and Other Chemistry Reagents) Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2000
through 2010 (includes corresponding Graph/Chart) III-78

Table 76: Asia-Pacific Long-term Projections for Clinical
Chemistry Analyzers and Reagents by Product Segment-
Analyzers (Large Volume Clinical Chemistry, Medium Sized
Clinical Chemistry, and Small Sized Clinical Chemistry), and
Reagents (Metabolite Chemistry Reagents, Enzyme Chemistry
Reagents, Electrolyte Chemistry Reagents, and Other
Chemistry Reagents) Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2011 through
2015 (includes corresponding Graph/Chart) III-79

Table 77: Asia-Pacific 10-Year Perspective for Clinical
Chemistry Analyzers and Reagents by Product Segment –
Percentage Breakdown of Dollar Sales for Analyzers (Large
Volume Clinical Chemistry, Medium Sized Clinical Chemistry,
and Small Sized Clinical Chemistry), and Reagents
(Metabolite Chemistry Reagents, Enzyme Chemistry Reagents,
Electrolyte Chemistry Reagents, and Other Chemistry
Reagents) Markets for 2003, 2008 & 2012 (includes
corresponding Graph/Chart) III-80

6. Latin America III-81
A. Market Analytics III-81
Current and Future Analysis III-81
Mexico III-81
B.Market Analytics III-82
Table 78: Latin America Recent Past, Current & Future
Analysis for Clinical Chemistry Analyzers and Reagents by
Product Segment- Analyzers (Large Volume Clinical Chemistry,
Medium Sized Clinical Chemistry, and Small Sized Clinical
Chemistry), and Reagents (Metabolite Chemistry Reagents,
Enzyme Chemistry Reagents, Electrolyte Chemistry Reagents,
and Other Chemistry Reagents) Markets Independently
Analyzed with Annual Sales Figures in US$ Million for
Years 2000 through 2010 (includes corresponding
Graph/Chart) III-82

Table 79: Latin America Long-term Projections for Clinical
Chemistry Analyzers and Reagents by Product Segment-
Analyzers (Large Volume Clinical Chemistry, Medium Sized
Clinical Chemistry, and Small Sized Clinical Chemistry),
and Reagents (Metabolite Chemistry Reagents, Enzyme
Chemistry Reagents, Electrolyte Chemistry Reagents, and
Other Chemistry Reagents) Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2011
through 2015 (includes corresponding Graph/Chart) III-83

Table 80: Latin America 10-Year Perspective for Clinical
Chemistry Analyzers and Reagents by Product Segment -
Percentage Breakdown of Dollar Sales for Analyzers (Large
Volume Clinical Chemistry, Medium Sized Clinical Chemistry,
and Small Sized Clinical Chemistry), and Reagents
(Metabolite Chemistry Reagents, Enzyme Chemistry Reagents,
Electrolyte Chemistry Reagents, and Other Chemistry
Reagents) Markets for 2003, 2008 & 2012 (includes
corresponding Graph/Chart) III-84


IV. COMPETITIVE LANDSCAPE


The Companies Mentioned are as follows:Abaxis, Inc (USA)
Abbott Diagnostics (USA)
Abbott Laboratories (USA)Alfa Wassermann, Inc (USA)
Amresco, Inc (USA)
Astoria-Pacific, Inc (USA)
Axon Lab AG (Switzerland)
Bayer AG (Germany)Bayer HealthCare -Diagnostic Div (Canada)BD Diagnostic Systems (USA)
Beckman Coulter, Inc (USA)Becton, Dickinson & Co (USA)Biocell Laboratories, Inc (USA)
Biocode Hycel (Belgium)
Biomerieux Italia SpA (Italy)
BioMerieux SA (France)
Biomerieux, Inc (USA)
Bio-Rad Laboratories, Inc (USA)
Celsis International PLC (UK)
Centronic GmbH (Germany)
Cholestech Corporation (USA)Chromogenix Instrumentation Laboratory SpA (Italy)
Dade Behring, Inc (USA)Daiichi Pure Chemicals Co, Ltd (Japan)
Delta Biologicals Srl (Italy)
Diagnostic Chemicals Limited (Canada)
Diagnostic Systems Laboratories, Inc (USA)
DiaMed AG (Switzerland)
Damedix Corporation (USA)
Dipro Med Handels GmbH (Austria)
EMD Chemicals, Inc (USA)
ESA, Inc (USA)
Fisher Scientific International, Inc (USA)
Hemagen Diagnostics Inc (USA)
Heska Corporation (USA)
Horiba Ltd (Japan)
Horizon Diagnostics, Inc (USA)
Idexx Laboratories, Inc (USA)
Immunovision, Inc (USA)
Instrumentation Laboratory SpA (Italy)
Ivax Diagnostics, Inc (USA)
Johnson & Johnson (USA)
Kamiya Biomedical Company (USA)
Lee Laboratories (USA)
Linco Research, Inc (USA)
LW Scientific (USA)
Medi